The abstract is read at the publisher; the summary is JClub's.
Eosinophilic gastritis is a rare, chronic stomach disease marked by dense eosinophilic infiltration and gastrointestinal symptoms, with no approved treatments and suboptimal long-term options.
- Why it matters: The field lacks effective, approved therapies and faces diagnostic challenges because eosinophilia must be confirmed on gastric biopsies after excluding other causes.
- What they did: The review synthesizes current evidence that food antigens may trigger type 2 immune dysregulation, including interleukins 4 and 13 upregulation, and outlines diagnostic criteria using endoscopy plus biopsy.
- The result: It highlights unmet needs for better management and notes that ongoing biologic clinical studies could potentially improve future clinical care for EoG.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.